Status:
COMPLETED
Survey of Procedures and Resources for Initiating Treatment of HIV in Africa-Zambia
Lead Sponsor:
Boston University
Collaborating Sponsors:
Bill and Melinda Gates Foundation
University of Witwatersrand, South Africa
Conditions:
HIV
Antiretroviral Therapy
Eligibility:
All Genders
18+ years
Brief Summary
In its 2017 revision of the global guidelines for HIV care and treatment, the World Health Organization (WHO) called for rapid or same-day initiation of antiretroviral treatment (ART) for eligible pat...
Eligibility Criteria
Inclusion
- ≥18 years old
- HIV-positive
Exclusion
- Pregnant
Key Trial Info
Start Date :
September 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2024
Estimated Enrollment :
2189 Patients enrolled
Trial Details
Trial ID
NCT04470011
Start Date
September 15 2020
End Date
December 1 2024
Last Update
December 27 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Health Economics and Epidemiology Research Office
Johannesburg, Gauteng, South Africa, 2193
2
Clinton Health Access Initiative
Lusaka, Zambia